LON/0QIU (LON/0QIU)

London Stock Exchange: LON/0QIU · DKK

DKK 259

-0.80 (-0.3%)· Recorded snapshot

Market cap	126.4B
Revenue (ttm)	37.9B
Net income (ttm)	13.4B
EPS (ttm)	DKK 2.93
P/E (trailing)	9.9x
P/E (forward)	11.5x
Dividend	DKK 1.37 (4.71%)
Volume	914,650
Beta	0.24

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 37.9B
Net income (ttm): 13.4B
EPS (ttm): DKK 2.93
P/E (trailing): 9.9x
P/E (forward): 11.5x
Market cap: 126.4B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E11.5

P25 n/aP50 n/aP75 n/a

Trailing P/E9.9

P25 n/aP50 n/aP75 n/a

ROE59.8

P25 n/aP50 n/aP75 n/a

ROIC39.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

S&P 500+0.8%

Nasdaq Composite-1.0%

Dow Jones Industrial Average+1.9%

Russell 2000+0.3%

All LON/0QIU indicators

Market & fundamental data

Available fields

261

Groups with data

Currency

DKK

Showing 261 of 261 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	GBP
Country	Denmark
Country code	UK
Earnings date	2026-11-04
Employees	66,700
Employees change	-11,687
Employees growth	-14.91%
Enterprise value	DKK 137B
Exchange	London Stock Exchange
Financial currency	DKK
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1923
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	DK0062498333
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Last stock split date	2023-09-13
Last stock split type	Forward
Market cap	DKK 126.4B
Next earnings date	2026-11-04
Price	DKK 258.70
Price currency	DKK
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	lon/0QIU
Website	https://www.novonordisk.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	25.52x
Average P/E ratio (3Y)	26.67x
Average P/E ratio (5Y)	30.16x
Earnings yield	10.13%
EV/Earnings	10.22x
EV/EBIT	7.58x
EV/EBITDA	6.98x
EV/FCF	15.69x
EV/Sales	3.71x
FCF / EV yield	6.37%
FCF yield	6.91%
Forward P/E	11.49x
Graham number	179.5196
Graham upside	-30.61%
Lynch fair value	DKK 584.47
Lynch upside	125.92%
P/(FCF - SBC) ratio	14.75x
P/(OCF - SBC) ratio	8.41x
P/B ratio	4.96x
P/E ratio	9.88x
P/FCF ratio	14.47x
P/OCF ratio	8.32x
P/S ratio	3.33x
Price / tangible book value	11.06x
Price/EBITDA ratio	6.32x
Sector forward P/E	14.49x
Sector P/E	22.58x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	48.99%
EBITDA margin	52.72%
Effective tax rate	21.72%
FCF margin	23.67%
Gross margin	81.99%
Operating margin	48.99%
Pretax margin	45.15%
Profit margin	35.35%
Profit per employee	DKK 201,067
Profitable quarters	164
Profitable years	41
Revenue per employee	DKK 568,843
ROA	18.73%
ROA (5Y)	21.35%
ROCE	45.35%
ROE	59.82%
ROE (5Y)	74.56%
ROIC	39.22%
ROIC (5Y)	68.16%
SBC / revenue	0.44%
Tax / revenue	9.81%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	4.98%
EPS growth (Q)	-20.61%
EPS growth (QoQ)	-56.63%
EPS growth 10Y	14.01%
EPS growth 3Y	20.74%
EPS growth 5Y	22.33%
EPS growth years	31
FCF growth	14.3%
FCF growth (Q)	56.84%
FCF growth (QoQ)	232.92%
FCF growth 3Y	2.24%
FCF growth 5Y	9.51%
Gross profit growth	2.76%
Gross profit growth (Q)	-4.1%
Gross profit growth 3Y	16.73%
Gross profit growth 5Y	20.17%
Net income growth	4.84%
Net income growth (Q)	-20.81%
Net income growth (QoQ)	-56.77%
Net income growth 3Y	20.09%
Net income growth 5Y	21.29%
Net income growth years	38
OCF growth	7.52%
OCF growth (Q)	32.14%
OCF growth (QoQ)	129.19%
OCF growth 10Y	11.56%
OCF growth 3Y	13.7%
OCF growth 5Y	19.47%
Operating income growth	9.29%
Operating income growth (Q)	-0.18%
Operating income growth 3Y	22.91%
Operating income growth 5Y	24.43%
Revenue growth	5.61%
Revenue growth (Q)	2.12%
Revenue growth (QoQ)	-18.94%
Revenue growth 10Y	11.56%
Revenue growth 3Y	17.84%
Revenue growth 5Y	20.45%
Revenue growth quarters	2
Revenue growth years	8

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	DKK -6.5B
Depreciation and amortization	DKK 1.4B
EBIT	DKK 18.6B
EBITDA	DKK 20B
EPS	DKK 2.93
Financing cash flow	DKK -2.6B
Free cash flow	DKK 8.7B
Free cash flow minus SBC	DKK 8.6B
Gross profit	DKK 31.1B
Income taxes	DKK 3.7B
Investing cash flow	DKK -9.6B
Net borrowing	DKK 4.1B
Net cash flow	DKK 3B
Net income	DKK 13.4B
Operating cash flow minus SBC	DKK 15B
Operating income	DKK 18.6B
Revenue	DKK 37.9B
Stock-based compensation	DKK 165.3M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	4.21
Book value per share	DKK 5.76
Debt / EBITDA	0.8
Debt / equity	0.63
Debt / FCF	1.85
Goodwill	DKK 2.2B
Interest coverage	1,566.84
Long-term assets	DKK 45.1B
Long-term liabilities	DKK 16.3B
Net cash (debt)	DKK -11B
Net cash / market cap	-8.67%
Net debt / EBITDA	0.55
Net debt / equity	0.43
Net debt / FCF	1.25
Piotroski F-Score	5
Property, plant and equipment	DKK 26B
Shareholders' equity	DKK 25.5B
Tangible book value	DKK 11.4B
Tangible book value per share	DKK 2.58
Total assets	DKK 68.5B
Total cash	DKK 5.2B
Total debt	DKK 16.1B
Total liabilities	DKK 43B
WACC	4.96%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.61
Current assets	DKK 23.4B
Current liabilities	DKK 26.8B
Current ratio	0.87
Inventory turnover	1.22
Net working capital	DKK -6.6B
Quick ratio	0.64
Working capital	DKK -3.5B
Working capital turnover	-1.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.14%
Dividend growth	0.43%
Dividend growth (10Y)	9.55%
Dividend growth (3Y)	18.26%
Dividend growth (5Y)	20.14%
Dividend growth years	8
Dividend payment date	2026-08-18
Dividend payment years	29
Dividend payout frequency	Semi-Annual
Dividend per share	DKK 1.37
Dividend yield	4.71%
Ex-dividend date	2026-08-14
Last dividend	DKK 3.75
Payout ratio	44.64%
Shareholder yield	4.85%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	85.73%
10Y return CAGR	8.91%
10Y total return	134.75%
150-day SMA	DKK 283.33
15Y price change	346.77%
15Y return CAGR	12.96%
15Y total return	522.11%
1D price change	-0.31%
1M price change	2.57%
1M total return	2.57%
1W price change	-0.65%
1W total return	-0.65%
1Y price change	-23.25%
1Y return CAGR	-19.6%
1Y total return	-19.59%
20-day SMA	DKK 256.03
200-day SMA	DKK 287.02
20Y price change	1,027.04%
20Y return CAGR	15.24%
20Y total return	1,604.98%
3M price change	-20.03%
3M total return	-19.01%
3Y price change	-60.82%
3Y return CAGR	-24.69%
3Y total return	-57.3%
50-day SMA	DKK 271.65
50-day SMA vs 200-day SMA	50under200
52-week high	DKK 409.90
52-week high date	2026-01-23
52-week low	DKK 224.55
52-week low date	2026-03-02
5Y price change	-23.92%
5Y return CAGR	-3.15%
5Y total return	-14.79%
6M price change	-1.52%
6M total return	-0.26%
All-time high	DKK 1,032.20
All-time high date	2024-06-26
All-time low	DKK 23.45
All-time low date	2009-04-15
Average true range (ATR)	DKK 6.79
Average volume	671.4K
Beta (5Y)	0.24
Change from 52-week high	-36.89%
Change from 52-week low	15.21%
Change from all-time high	-74.86%
Change from all-time low	1,006.61%
Change from open	-0.12%
Day's gap	-0.19%
Dollar volume	DKK 236.6M
High price	DKK 264.09
Low price	DKK 255.00
Monthly RSI	35.95
Open price	DKK 259.00
Position in 52-week range	40.7%
Previous close	DKK 259.50
Price vs 150-day SMA	-8.41%
Price vs 20-day SMA	1.36%
Price vs 200-day SMA	-9.59%
Price vs 50-day SMA	-4.47%
Relative volume	1.4
RSI	46.19
Sharpe ratio	-0.32
Sharpe ratio (3Y)	-0.55
Sharpe ratio (5Y)	0.02
Sortino ratio	-0.3
Sortino ratio (3Y)	-0.58
Sortino ratio (5Y)	0.16
Volume	914.7K
Weekly RSI	40.48
YTD price change	-20.63%
YTD total return	-16.84%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3.2B
Shares change (QoQ)	-0.29%
Shares change (YoY)	-0.14%
Shares held by insiders	0.02%
Shares held by institutions	27.52%

Deeper analysis on LON/0QIU

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Six-factor overlay and 9-category weighted scorecard.

→

Recommendation

Final action, action steps, opportunity, and biggest risk.

→

Perspectives

Growth, value, and income investor reads.

→

Frequently asked questions

About this LON/0QIU report

Is a complete LON/0QIU research report available?

No complete published report is available for lon/0QIU (LON/0QIU) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Market cap

126.4B

Revenue (ttm)

37.9B

Net income (ttm)

13.4B

EPS (ttm)

DKK 2.93

P/E (trailing)

9.9x

P/E (forward)

11.5x

Dividend

DKK 1.37 (4.71%)

Volume

914,650

Beta

0.24

Metric

Value

Amount currency

GBP

Country

Denmark

Country code

Earnings date

2026-11-04

Employees

66,700

Employees change

-11,687

Employees growth

-14.91%

Enterprise value

DKK 137B

Exchange

London Stock Exchange

Financial currency

DKK

Financial report date

2026-06-30

First seen

2026-05-10

Fiscal year end

December

Founded

1923

Industry

Drug Manufacturers - General

Is primary listing

ISIN number

DK0062498333

Last earnings date

2026-08-05

Last refreshed

2026-10-28

Last stock split date

2023-09-13

Last stock split type

Forward

Market cap

DKK 126.4B

Next earnings date

2026-11-04

Price

DKK 258.70

Price currency

DKK

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

lon/0QIU

Website

https://www.novonordisk.com

Metric

Value

Average P/E ratio (10Y)

25.52x

Average P/E ratio (3Y)

26.67x

Average P/E ratio (5Y)

30.16x

Earnings yield

10.13%

EV/Earnings

10.22x

EV/EBIT

7.58x

EV/EBITDA

6.98x

EV/FCF

15.69x

EV/Sales

3.71x

FCF / EV yield

6.37%

FCF yield

6.91%

Forward P/E

11.49x

Graham number

179.5196

Graham upside

-30.61%

Lynch fair value

DKK 584.47

Lynch upside

125.92%

P/(FCF - SBC) ratio

14.75x

P/(OCF - SBC) ratio

8.41x

P/B ratio

4.96x

P/E ratio

9.88x

P/FCF ratio

14.47x

P/OCF ratio

8.32x

P/S ratio

3.33x

Price / tangible book value

11.06x

Price/EBITDA ratio

6.32x

Sector forward P/E

14.49x

Sector P/E

22.58x

Metric

Value

EBIT margin

48.99%

EBITDA margin

52.72%

Effective tax rate

21.72%

FCF margin

23.67%

Gross margin

81.99%

Operating margin

48.99%

Pretax margin

45.15%

Profit margin

35.35%

Profit per employee

DKK 201,067

Profitable quarters

164

Profitable years

Revenue per employee

DKK 568,843

ROA

18.73%

ROA (5Y)

21.35%

ROCE

45.35%

ROE

59.82%

ROE (5Y)

74.56%

ROIC

39.22%

ROIC (5Y)

68.16%

SBC / revenue

0.44%

Tax / revenue

9.81%

Metric

Value

EPS growth

4.98%

EPS growth (Q)

-20.61%

EPS growth (QoQ)

-56.63%

EPS growth 10Y

14.01%

EPS growth 3Y

20.74%

EPS growth 5Y

22.33%

EPS growth years

FCF growth

14.3%

FCF growth (Q)

56.84%

FCF growth (QoQ)

232.92%

FCF growth 3Y

2.24%

FCF growth 5Y

9.51%

Gross profit growth

2.76%

Gross profit growth (Q)

-4.1%

Gross profit growth 3Y

16.73%

Gross profit growth 5Y

20.17%

Net income growth

4.84%

Net income growth (Q)

-20.81%

Net income growth (QoQ)

-56.77%

Net income growth 3Y

20.09%

Net income growth 5Y

21.29%

Net income growth years

OCF growth

7.52%

OCF growth (Q)

32.14%

OCF growth (QoQ)

129.19%

OCF growth 10Y

11.56%

OCF growth 3Y

13.7%

OCF growth 5Y

19.47%

Operating income growth

9.29%

Operating income growth (Q)

-0.18%

Operating income growth 3Y

22.91%

Operating income growth 5Y

24.43%

Revenue growth

5.61%

Revenue growth (Q)

2.12%

Revenue growth (QoQ)

-18.94%

Revenue growth 10Y

11.56%

Revenue growth 3Y

17.84%

Revenue growth 5Y

20.45%

Revenue growth quarters

Revenue growth years

Metric

Value

Capital expenditures

DKK -6.5B

Depreciation and amortization

DKK 1.4B

EBIT

DKK 18.6B

EBITDA

DKK 20B

EPS

DKK 2.93

Financing cash flow

DKK -2.6B

Free cash flow

DKK 8.7B

Free cash flow minus SBC

DKK 8.6B

Gross profit

DKK 31.1B

Income taxes

DKK 3.7B

Investing cash flow

DKK -9.6B

Net borrowing

DKK 4.1B

Net cash flow

DKK 3B

Net income

DKK 13.4B

Operating cash flow minus SBC

DKK 15B

Operating income

DKK 18.6B

Revenue

DKK 37.9B

Stock-based compensation

DKK 165.3M

Metric

Value

Altman Z-Score

4.21

Book value per share

DKK 5.76

Debt / EBITDA

0.8

Debt / equity

0.63

Debt / FCF

1.85

Goodwill

DKK 2.2B

Interest coverage

1,566.84

Long-term assets

DKK 45.1B

Long-term liabilities

DKK 16.3B

Net cash (debt)

DKK -11B

Net cash / market cap

-8.67%

Net debt / EBITDA

0.55

Net debt / equity

0.43

Net debt / FCF

1.25

Piotroski F-Score

Property, plant and equipment

DKK 26B

Shareholders' equity

DKK 25.5B

Tangible book value

DKK 11.4B

Tangible book value per share

DKK 2.58

Total assets

DKK 68.5B

Total cash

DKK 5.2B

Total debt

DKK 16.1B

Total liabilities

DKK 43B

WACC

4.96%

Metric

Value

Asset turnover

0.61

Current assets

DKK 23.4B

Current liabilities

DKK 26.8B

Current ratio

0.87

Inventory turnover

1.22

Net working capital

DKK -6.6B

Quick ratio

0.64

Working capital

DKK -3.5B

Working capital turnover

-1.01

Metric

Value

Buyback yield / dilution

0.14%

Dividend growth

0.43%

Dividend growth (10Y)

9.55%

Dividend growth (3Y)

18.26%

Dividend growth (5Y)

20.14%

Dividend growth years

Dividend payment date

2026-08-18

Dividend payment years

Dividend payout frequency

Semi-Annual

Dividend per share

DKK 1.37

Dividend yield

4.71%

Ex-dividend date

2026-08-14

Last dividend

DKK 3.75

Payout ratio

44.64%

Shareholder yield

4.85%

Metric

Value

10Y price change

85.73%

10Y return CAGR

8.91%

10Y total return

134.75%

150-day SMA

DKK 283.33

15Y price change

346.77%

15Y return CAGR

12.96%

15Y total return

522.11%

1D price change

-0.31%

1M price change

2.57%

1M total return

2.57%

1W price change

-0.65%

1W total return

-0.65%

1Y price change

-23.25%

1Y return CAGR

-19.6%

1Y total return

-19.59%

20-day SMA

DKK 256.03

200-day SMA

DKK 287.02

20Y price change

1,027.04%

20Y return CAGR

15.24%

20Y total return

1,604.98%

3M price change

-20.03%

3M total return

-19.01%

3Y price change

-60.82%

3Y return CAGR

-24.69%

3Y total return

-57.3%

50-day SMA

DKK 271.65

50-day SMA vs 200-day SMA

50under200

52-week high

DKK 409.90

52-week high date

2026-01-23

52-week low

DKK 224.55

52-week low date

2026-03-02

5Y price change

-23.92%

5Y return CAGR

-3.15%

5Y total return

-14.79%

6M price change

-1.52%

6M total return

-0.26%

All-time high

DKK 1,032.20

All-time high date

2024-06-26

All-time low

DKK 23.45

All-time low date

2009-04-15

Average true range (ATR)

DKK 6.79

Average volume

671.4K

Beta (5Y)

0.24

Change from 52-week high

-36.89%

Change from 52-week low

15.21%

Change from all-time high

-74.86%

Change from all-time low

1,006.61%

Change from open

-0.12%

Day's gap

-0.19%

Dollar volume

DKK 236.6M

High price

DKK 264.09

Low price

DKK 255.00

Monthly RSI

35.95

Open price

DKK 259.00

Position in 52-week range

40.7%

Previous close

DKK 259.50

Price vs 150-day SMA

-8.41%

Price vs 20-day SMA

1.36%

Price vs 200-day SMA

-9.59%

Price vs 50-day SMA

-4.47%

Relative volume

1.4

RSI

46.19

Sharpe ratio

-0.32

Sharpe ratio (3Y)

-0.55

Sharpe ratio (5Y)

0.02

Sortino ratio

-0.3

Sortino ratio (3Y)

-0.58

Sortino ratio (5Y)

0.16

Volume

914.7K

Weekly RSI

40.48

YTD price change

-20.63%

YTD total return

-16.84%

Metric

Value

Float

3.2B

Shares change (QoQ)

-0.29%

Shares change (YoY)

-0.14%

Shares held by insiders

0.02%

Shares held by institutions

27.52%

LON/0QIU (LON/0QIU)

Price

Financial snapshot

Fair-value bridge

Latest news · LON/0QIU

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LON/0QIU indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on LON/0QIU

Frequently asked questions

LON/0QIU (LON/0QIU)

Price

Financial snapshot

Fair-value bridge

Latest news · LON/0QIU

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LON/0QIU indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on LON/0QIU

Frequently asked questions